Hostname: page-component-586b7cd67f-t7czq Total loading time: 0 Render date: 2024-11-23T06:52:41.726Z Has data issue: false hasContentIssue false
  • English
  • Français

Release of inflammatory mediators in irradiated cell salvage blood and their biological consequences in human beings following transfusion

Published online by Cambridge University Press:  23 December 2004

B. Beck-Schimmer ,
B. Romero ,
C. Booy ,
H. Joch ,
U. Haller ,
T. Pasch  and
D. R. Spahn
B. Beck-Schimmer
Affiliation:
University Hospital, Institute of Anaesthesiology, Zurich, Switzerland University Hospital, Institute of Physiology, Zurich, Switzerland
B. Romero
Affiliation:
University Hospital, Institute of Anaesthesiology, Zurich, Switzerland
C. Booy
Affiliation:
University Hospital, Institute of Physiology, Zurich, Switzerland
H. Joch
Affiliation:
University of Zurich, Institute of Physiology, Cardiovascular Research, Zurich, Switzerland
U. Haller
Affiliation:
University Hospital, Department of Gynaecology, Zurich, Switzerland
T. Pasch
Affiliation:
University Hospital, Institute of Anaesthesiology, Zurich, Switzerland
D. R. Spahn
Affiliation:
University Hospital, Institute of Anaesthesiology, Lausanne, Switzerland
Get access

Extract

Summary

Background and objective: Irradiation of intraoperative cell salvage blood has recently been used to inactivate tumour cells before retransfusion, during cancer surgery. No information is available about a potential inflammatory response of the recipient to the retransfusion of irradiated intraoperative cell salvage blood. This pilot study was conducted to investigate the possible release of the pro-inflammatory mediators, tumour necrosis factor-α (TNF-α), interleukin-1β (IL-1β), eotaxin and monocyte chemo-attractant protein-1 (MCP-1), in the serum of recipients by intraoperative retransfusion of irradiated intraoperative cell salvage blood.

Methods: Nine patients undergoing gynaecological cancer surgery were included in this study. Intraoperative cell salvage blood was irradiated with 50 Gy and retransfused to the patient. Serum and intraoperative cell salvage blood concentrations of TNF-α, IL-1β, eotaxin and MCP-1 were repeatedly analysed before and after retransfusion, respectively before and after irradiation.

Results: Traces of mediators were detected in intraoperative cell salvage blood but no increase due to irradiation was observed. Following transfusion of intraoperative cell salvage blood, minute quantities (all <30 pg mL−1) of mediators were detected in the serum of patients. However, there was no significant upregulation compared to serum values before retransfusion.

Conclusions: These results provide evidence that retransfusion of irradiated intraoperative cell salvage blood might represent a blood-saving strategy in cancer surgery without an immunological inflammatory response as shown by a lack of upregulation of inflammatory mediators.

Keywords

BLOOD TRANSFUSION, autologousIMMUNOLOGICAL FACTORS, cytokinesINFLAMMATION MEDIATORS, chemokinesRADIATIONRADIOBIOLOGYSURGICAL PROCEDURES OPERATIVE, pelvic exenteration
Type
Original Article
Information
European Journal of Anaesthesiology , Volume 21 , Issue 1 , January 2004 , pp. 46 - 52
Copyright
2004 European Society of Anaesthesiology

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Desmond MJ, Thomas MJ, Gillon J, Fox MA. Consensus conference on autologous transfusion. Perioperative red cell salvage. Transfusion 1996; 36: 644–651.Google Scholar
Huet C, Salmi LR, Fergusson D, Koopman-van Gemert AW, Rubens F, Laupacis A. A meta-analysis of the effectiveness of cell salvage to minimize perioperative allogeneic blood transfusion in cardiac and orthopedic surgery. International Study of Perioperative Transfusion (ISPOT) Investigators. Anesth Analg 1999; 89: 861–869.Google Scholar
Spahn DR, Casutt M. Eliminating blood transfusions. Anesthesiology 2000; 93: 242–255.Google Scholar
Hansen E, Wolff N, Knuechel R, Ruschoff J, Hofstaedter F, Taeger K. Tumor cells in blood shed from the surgical field. Arch Surg 1995; 130: 387–393.Google Scholar
Dale RF, Kipling RM, Smith MF, Collier DS, Smith PJ. Separation of malignant cells during autotransfusion. Br J Surg 1988; 75: 581.Google Scholar
Wiesel M, Güdemann C, Staehler G. Tumour cell separation by cell saver and membrane filter passage. Infusionstherapie 1991; 18: 143–144.Google Scholar
Torre GC, Ferrari M, Favre A, Razzetta F, Borgonovo G. A new technique for intraoperative blood recovery in the cancer patient. Eur J Surg Oncol 1994; 20: 565–570.Google Scholar
Karczewski DM, Lema MJ, Glaves D. The efficiency of an autotransfusion system for tumor cell removal from blood salvaged during cancer surgery. Anesth Analg 1994; 78: 1131–1135.Google Scholar
Kongsgaard UE, Wang MY, Kvalheim G. Leucocyte depletion filter removes cancer cells in human blood. Acta Anaesthesiol Scand 1996; 40: 118–120.Google Scholar
Hansen E, Knuechel R, Altmeppen J, Taeger K. Blood irradiation for intraoperative autotransfusion in cancer surgery: demonstration of efficient elimination of contaminating tumor cells. Transfusion 1999; 39: 608–614.Google Scholar
Muylle L, Joos M, Wouters E, De Bock R, Peetermans ME. Increased tumor necrosis factor a (TNFα), interleukin 1, and interleukin 6 (IL-6) levels in the plasma of stored platelet concentrates: relationship between TNFα and IL-6 and febrile transfusion reactions. Transfusion 1993; 33: 195–199.Google Scholar
Hallahan DE, Haimovitz-Friedman A, Kufe DW, Fuks Z, Weichselbaum RR. The role of cytokines in radiation oncology. Important Adv Oncol 1993: 71–80.Google Scholar
Kerr NC, Wright EG, Plumb MA. p53-dependent X-ray-induced modulation of cytokine mRNA levels in vivo. J Pathol 1998; 186: 24–30.Google Scholar
Davenport R. Cytokines and erythrocyte incompatibility. Curr Opin Hematol 1994; 1: 452–456.Google Scholar
Taha RA, Minshall EM, Leung DY, et al. Evidence for increased expression of eotaxin and monocyte chemotactic protein-4 in atopic dermatitis. J Allergy Clin Immunol 2000; 105: 1002–1007.Google Scholar
Texeira MM, Wells TN, Lukacs NW, et al. Chemokine-induced eosinophil recruitment. Evidence of a role for endogenous exotaxin an in vivo allergy model in mouse skin. J Clin Invest 1997; 100: 1657–1666.Google Scholar
Hogan SP, Mishra A, Brandt EB, Foster PS, Rothenberg ME. A critical role for eotaxin in experimental oral antigen-induced eosinophilic gastrointestinal allergy. Proc Natl Acad Sci USA 2000; 97: 6681–6686.Google Scholar
Aukrust P, Ueland T, Muller F, et al. Elevated circulating levels of C–C chemokines in patients with congestive heart failure. Circulation 2000; 97: 1136–1143.Google Scholar
Yoong KF, Afford SC, Jones R, et al. Expression and function of CXC and CC chemokines in human malignant liver tumors: a role for human monokine induced by gamma-interferon in lymphocyte recruitment to hepatocellular carcinoma. Hepatology 1999; 30: 100–111.Google Scholar
Salcedo R, Ponce ML, Young HA, et al. Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. Blood 2000; 96: 34–40.Google Scholar
Davenport RD, Burdick M, Strieter RM, Kunkel SL. Monocyte chemo-attractant protein production in red cell incompatibility. Transfusion 1994; 34: 16–19.Google Scholar
Beck-Schimmer B, Schimmer RC, Warner RL, et al. Expression of lung vascular and airway ICAM-1 after exposure to bacterial lipopolysaccharide. Am J Respir Cell Mol Biol 1997; 17: 344–352.Google Scholar
Beck-Schimmer B, Schimmer RC, Schmal H, et al. Characterization of rat lung ICAM-1. Inflamm Res 1998; 47: 308–315.Google Scholar
Pons I, Gras G, Courberand S, Benveniste O, Dormont D. Consequences of gamma-irradiation on inflammatory cytokine regulation in human monocytes/macrophages. Int J Radiat Biol 1997; 71: 157–166.Google Scholar
Weinmann M, Belka C, Scheiderbauer J, Bamberg M. Soluble levels of CD-95, CD 95-L and various cytokines after exposing human leukocytes to ionizing radiation. Anticancer Res 2000; 20 (3A): 1813–1818.Google Scholar
Fujihara M, Takahashi TA, Ogiso C, Hosoda M, Ikebuchi K, Sekiguchi S. Generation of interleukin 8 in stored apheresis platelet concentrates and the preventive effect of prestorage ultraviolet B radiation. Transfusion 1997; 37: 468–475.Google Scholar
Klein HG. Immunomodulatory aspects of transfusion: a once and future risk?. Anesthesiology 1999; 91: 861–865.Google Scholar
Blumberg N, Heal JM. Effects on transfusion on immune function. Arch Pathol Lab 1994; 118: 371–379.Google Scholar
Mickler TA, Longnecker DE. The immunosuppressive aspects of blood transfusion. J Intensive Care Med 1992; 7: 176–188.Google Scholar
Fransen E, Maessen J, Dentener M, Senden N, Buurman W. Impact of blood transfusion on inflammatory mediator release in patients undergoing cardiac surgery. Chest 1999; 116: 1233–1239.Google Scholar
Bengtson JP, Backman L, Stenqvist O, Heideman M, Bengtsson A. Complement activation and reinfusion of wound drainage blood. Anesthesiology 1990; 73: 376–380.Google Scholar
Arnestad JP, Bengtsson A, Bengtson JP, Tylman M, Redl H, Schlag G. Formation of cytokines by retransfusion of shed whole blood. Br J Anaesth 1994; 72: 422–425.Google Scholar
Kristiansson M, Soop M, Saraste L, Sundqvist KG. Cytokines in stored red blood cell concentrates: promoters of systemic inflammation and simulators of acute transfusion reactions? Acta Anaesthesiol Scand 1996; 40: 496–501.Google Scholar
Jeng JC, Boyd TM, Jablonski KA, Harviel JD, Jordan MH. Intraoperative blood salvage in excisional burn surgery: an analysis of yield, bacteriology and inflammatory mediators. J Burn Care Rehabil 1998; 19: 305–311.Google Scholar
Ellstöm M, Bentsson A, Tylman M, Haeger M, Olsson JH, Hahlin M. Evaluation of tissue trauma after laparoscopic and abdominal hysterectomy: measurements of neutrophil activation and release of interleukin-6, cortisol, and C-reactive protein. Am J Coll Surg 1996; 182: 423–430.Google Scholar
Avall A, Hyllner M, Bengtson JP, Carlsson L, Bengtsson A. Greater increase in cytokine concentration after salvage with filtered whole blood than with washed red cells, but no difference in postoperative hemoglobin recovery. Transfusion 1999; 39: 271–276.Google Scholar
Jacobi KE, Wanke C, Jacobi A, Weisbach V. Determination of eicosanoid and cytokine production in salvaged blood, stored red blood cell concentrates, and whole blood. J Clin Anesth 2000; 12: 94–99.Google Scholar
Rohling RG, Zimmermann AP, Zellweger R, Schanz U. Transfusion of washed and centrifuged shed RBCs during maxillofacial surgery affects cytokine concentrations. Transfusion 2000; 40: 1352–1356.Google Scholar
Hefler L, Tempfer C, Heinze G, et al. Monocyte chemo-attractant protein-1 serum levels in ovarian cancer patients. Br J Cancer 1999; 81: 855–859.Google Scholar
Kunke D, Grimm D, Denger S, et al. Preclinical study on gene therapy of cervical carcinoma using adeno-associated virus vectors. Cancer Gene Ther 2000; 7: 766–777.Google Scholar
Wadhwa M, Thorpe R. Cytokine immunoassays: recommendations for standardisation, calibration and validation. J Immunol Meth 1998; 219: 1–5.Google Scholar
Banks RE. Measurement of cytokines in clinical samples using immunoassays: problems and pitfalls. Crit Rev Clin Lab Sci 2000; 37: 131–182.Google Scholar
Schmidt H, Bendtzen K, Mortensen PE. The inflammatory cytokine response after autotransfusion of shed mediastinal blood. Acta Anaesthesiol Scand 1998; 42: 558–564.Google Scholar